Insmed Stock Buy Hold or Sell Recommendation

INSM Stock  USD 26.17  0.17  0.65%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Insmed Inc is 'Strong Buy'. Macroaxis provides Insmed buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Insmed positions. The advice algorithm takes into account all of Insmed's available fundamental, technical, and predictive indicators you will find on this site.
Real Value
Target Price
Hype Value
Market Value
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Insmed Inc given historical horizon and risk tolerance towards Insmed. When Macroaxis issues a 'buy' or 'sell' recommendation for Insmed Inc, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Insmed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Insmed and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Execute Insmed Buy or Sell Advice

The Insmed recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Insmed Inc. Macroaxis does not own or have any residual interests in Insmed Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Insmed's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell InsmedBuy Insmed
Strong Buy

Market Performance




Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

For the selected time horizon Insmed Inc has a Risk Adjusted Performance of 0.0946, Jensen Alpha of 0.3844, Total Risk Alpha of 0.4565, Sortino Ratio of 0.2593 and Treynor Ratio of 2.0
Our trade recommendations module complements current analysts and expert consensus on Insmed Inc. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Insmed Inc is not overpriced, please check out all Insmed fundamentals, including its revenue, short ratio, current liabilities, as well as the relationship between the cash per share and market capitalization . Given that Insmed Inc has a number of shares shorted of 12.44 M, we strongly advise you to confirm Insmed Inc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Insmed Trading Alerts and Improvement Suggestions

The company reported the previous year's revenue of 245.36 M. Net Loss for the year was (481.53 M) with profit before overhead, payroll, taxes, and interest of 190.23 M.
Insmed Inc currently holds about 554.87 M in cash with (400.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.62.
Insmed Inc has a frail financial position based on the latest SEC disclosures
Over 99.0% of the company shares are owned by institutional investors
Latest headline from Insmed Insiders Sold US1.9m Of Shares Suggesting Hesitancy - Simply Wall St

Insmed Returns Distribution Density

The distribution of Insmed's historical returns is an attempt to chart the uncertainty of Insmed's future price movements. The chart of the probability distribution of Insmed stock daily returns describes the distribution of returns around its average expected value. We use Insmed Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Insmed returns is essential to provide solid investment advice for Insmed.
Mean Return
Value At Risk
Potential Upside
Standard Deviation
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Insmed historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Insmed Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Insmed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Insmed Inc backward and forwards among themselves. Insmed's institutional investor refers to the entity that pools money to purchase Insmed's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Last TransactionTypeSharesValue
Absolute Investment Advisers Llc2023-06-30Debt8.5 M7.1 B
Vanguard Group Inc2023-06-30Common Shares13.3 M281.1 M
Blackrock Inc2023-06-30Common Shares10.3 M216.4 M
Price T Rowe Associates Inc2023-06-30Common Shares10.2 M214.6 M
T Rowe Price Investment Management Inc2023-06-30Common Shares8.3 M175.2 M
Deep Track Capital Lp2023-06-30Common Shares6.5 M137.2 M
State Street Corp2023-06-30Common SharesM127 M
Palo Alto Investors Lp2023-06-30Common Shares5.9 M124.3 M
Macquarie Group Ltd2023-06-30Common Shares4.4 M92.7 M
William Blair Investment Management Llc2023-06-30Common Shares4.3 M90.4 M
Fmr Llc2023-06-30Common Shares4.1 M86.2 M
Note, although Insmed's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Insmed Cash Flow Accounts

201820192020202120222023 (projected)
Capital Expenditure(13.09 M)(42.27 M)(6.24 M)(7.29 M)(9.88 M)(10.66 M)
Depreciation Amortization and Accretion4.83 M19.94 M20.08 M26.77 M22.31 M24.07 M
Net Cash Flow or Change in Cash and Cash Equivalents113.91 M(7.64 M)45.33 M184.03 M357.25 M385.46 M
Issuance Purchase of Equity Shares8.81 M280.77 M271.94 M291.92 M311.66 M268.25 M
Net Cash Flow from Financing386.74 M285.28 M271 M612.55 M793.27 M855.9 M
Net Cash Flow from Investing(14.81 M)(42.27 M)(6.82 M)(64.28 M)(34.58 M)(35.49 M)
Net Cash Flow from Operations(257.98 M)(250.65 M)(219.35 M)(363.3 M)(400.44 M)(410.98 M)
Effect of Exchange Rate Changes on Cash(45 K)(4 K)494 K(933 K)(996 K)(1.02 M)
Share Based Compensation26.24 M26.97 M36.16 M46.02 M57.69 M62.24 M

Insmed Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Insmed or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Insmed's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Insmed stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over NYSE Composite
Beta against NYSE Composite0.19
Overall volatility
Information ratio 0.15

Insmed Volatility Alert

Insmed Inc has relatively low volatility with skewness of 3.34 and kurtosis of 17.88. However, we advise all investors to independently investigate Insmed Inc to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Insmed's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Insmed's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Insmed Fundamentals Vs Peers

Comparing Insmed's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Insmed's direct or indirect competition across all of the common fundamentals between Insmed and the related equities. This way, we can detect undervalued stocks with similar characteristics as Insmed or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Insmed's fundamental indicators could also be used in its relative valuation, which is a method of valuing Insmed by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Insmed to competition
FundamentalsInsmedPeer Average
Return On Equity-14.53-0.31
Return On Asset-0.33-0.14
Profit Margin(2.58) %(1.27) %
Operating Margin(2.43) %(5.51) %
Current Valuation4.21 B16.62 B
Shares Outstanding143.8 M571.82 M
Shares Owned by Insiders1.29 %10.09 %
Shares Owned by Institutions98.71 %39.21 %
Number of Shares Shorted12.44 M4.71 M
Price to Earning(8.70) X28.72 X
Price to Book48.18 X9.51 X
Price to Sales10.89 X11.42 X
Revenue245.36 M9.43 B
Gross Profit190.23 M27.38 B
EBITDA(458.21 M)3.9 B
Net Income(481.53 M)570.98 M
Cash and Equivalents554.87 M2.7 B
Cash per Share4.62 X5.01 X
Total Debt1.18 B5.32 B
Current Ratio5.93 X2.16 X
Book Value Per Share(1.09) X1.93 K
Cash Flow from Operations(400.44 M)971.22 M
Short Ratio10.06 X4.00 X
Earnings Per Share(5.43) X3.12 X
Target Price42.58
Number of Employees73618.84 K
Market Capitalization3.76 B19.03 B
Total Asset1.66 B29.47 B
Retained Earnings(2.7 B)9.33 B
Working Capital1.08 B1.48 B
Current Asset28.15 M9.34 B
Current Liabilities3.89 M7.9 B
Note: Sale by John Wise of 1913 shares of Insmed [view details]

About Insmed Buy or Sell Advice

When is the right time to buy or sell Insmed Inc? Buying financial instruments such as Insmed Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2020 2021 2022 2023 (projected)
Receivables16.56 M24.35 M29.71 M32.06 M
Inventories49.59 M67.01 M69.92 M55.48 M

Use Investing Ideas to Build Portfolios

In addition to having Insmed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate ETFs Thematic Idea Now

Real Estate ETFs
Real Estate ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Real Estate ETFs theme has 62 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Insmed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Correlations
Find global opportunities by holding instruments from different markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.